AGP Picks
View all

China Industry Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on China Industry Times.

Press releases published on May 19, 2026

Dr Angela Yu Appointed Founding Chair of ICI International Arts Education Outreach Committee
UnchainedTV Wins 19 Telly Awards in a Victory for Vegan TV Programming
Feng Cha Elevates Training & Hospitality Standards Across Its Growing Franchise System
Pressure Relief Devices Market Set to Witness Significant Growth by 2026-2033 | Invacare Corporation, Talley Group Ltd
Online Substation Monitoring System Market Set to Robust Growth at 7.7% CAGR Through 2033, Says Coherent Market Insights
Sir Gary Kong Shares Leadership Lessons, Entrepreneurial Advice, and a Commitment to Philanthropy
Refurbished Electronics Market Set to Expand to US$136.40 Bn by 2033, Says Coherent Market Insights
Thermal Camera Market to Reach US$11.92 Billion by 2033 Growing at 9.9% CAGR | Coherent Market Insights
Agile Project Management Software Market Set for Robust Growth at 14.1% CAGR Through 2033, Says Coherent Market Insights
Maritime Analytics Market to Reach US$4,759.0 Million by 2033 Growing at 14.1% CAGR | Coherent Market Insights
The World’s Real Estate Leaders Gather this November in the Capital of Real Estate at Cityscape Global 2026
Air Traffic Control Market Set to Expand to US$24.20 Bn by 2033, Says Coherent Market Insights
Unmanned Aerial Vehicle Market Set for Robust Growth at 10.8% CAGR Through 2033, According to Coherent Market Insights
Diesel Exhaust Fluid Market Size Worth USD 81.11 Billion by 2033, says Coherent Market Insights
Smart Powerr Corp. Announces $2 Million Registered Direct Offering
MAAS Subsidiary, Huazhi Future, Explores Green AI Computing Collaboration with Xinjiang Delegation and CGN
Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
リゼン・ファーマ、アルツハイマー病による軽度認知障害を対象としたRP902の、第2相治験の開始を発表
Risen Pharma, 알츠하이머병 관련 경도인지장애 치료제 RP902 임상 2상 개시 발표

Share this page:

Sign up for:

China Industry Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.